Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
France to build new nuclear aircraft carrier, Macron says - 2Equality requires universal draft, participation in economy and workforce, MK Liberman says
- 315 Outrageous Cosplay Outfits That Will Blow You Away
- 4Deaths reported in Lebanon as Israel and Hezbollah exchange attacks
- 5Bavarian leader questions Germany's Eurovision participation
- Getting through a Lifelong Change: Individual Examples of overcoming adversity
- Defense Minister Katz finally condemns Jewish extremist violence against Palestinians
- Step by step instructions to Keep up with Ideal Oral Cleanliness at Home
- Activists: Venezuela released just nine prisoners despite promise
- Find the Mysteries of Powerful Using time productively: Augmenting Efficiency and Proficiency
- IDF drops over 80 explosives on Tehran weapon production sites in latest strike
- India's top court hears challenges to ruling on women's entry into temple
- Europe: 4 Urban communities for a Paramount Social Experience
- Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered.
